| Trial ID: | L1692 |
| Source ID: | NCT01832558
|
| Associated Drug: |
Eplerenone
|
| Title: |
The EPOCH Study (Eplerenone on Top of ACE Inhibition in Chronic Kidney Disease Patients With Hypertension)
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
CKD II-III
|
| Interventions: |
DRUG: Eplerenone|DRUG: Placebo
|
| Outcome Measures: |
Primary: Angiotensin levels (pg/ml) of CKD II-III patients with DM II with eplerenone additional to enalapril in comparison to patients who receive a placebo on top of enalapril therapy., 1 year |
|
| Sponsor/Collaborators: |
Sponsor: Medical University of Vienna
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
24
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2012-11
|
| Completion Date: |
2021-12-31
|
| Results First Posted: |
|
| Last Update Posted: |
2020-06-19
|
| Locations: |
Medical University of Vienna, Vienna, 1090, Austria
|
| URL: |
https://clinicaltrials.gov/show/NCT01832558
|
